Mar 29, 5:56 PM EDT
Everything You Need To Know, Right Now.
Stay connected to the biggest stories unfolding in technology.
The IBTech Newsletter keeps you connected to the biggest stories unfolding in technology.
Please enter a valid email
Media & Culture
Instant view: U.S. advisers say keep Glaxo's Avandia on market
By IBT Staff Reporter on 07/14/10 AT 6:40 PM
U.S. health advisers voted on Wednesday to keep GlaxoSmithKline's Avandia diabetes drug on the market, with a majority of those in favor recommending the treatment carry additional warnings.